Regarding the association between COVID-19 and coagulation abnormalities, data from the literature suggest that while the von Willebrand factor (vWF) is upregulated, ADAMTS13, a metalloprotease that cleaves high-molecular-weight vWF, is downregulated. Here, VWF is linked to COVID-19.